Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells

Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells

US Patent 11932696 · Granted Mar 19, 2024

Estimated economic value: $194,413,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CTLA-4 antibody and use thereof2025
Method for simulating processing state of belt-shaped body2025
Method for predicting effect of tumor immunotherapy using tumor cytotoxic activi2025
Drug and production method therefor2024
Compound, and method for producing regulatory T cells2023
Compound, and method for producing regulatory T cells2023
T cell-redirected antigen-binding molecule for cells having immunosuppression fu2022
Method, biomarker and diagnostic agent for detection of high-risk prostate cance2022
Enteric coated silicon drug and production method therefor2021
Immunopotentiator potentiating tumor immunity or infection immunity2020
Immunopotentiator potentiating tumor immunity or infection immunity2020
Method of treating cancer with an anti-CCR8 having antibody-dependent cell-media2020